Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Recruiting

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

NCT06562543

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
View all 45 locations
View Trial Details
Recruiting

Early Onset Colorectal Cancer Detection

NCT06342401

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Adenocarcinoma, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • IRCCS San Raffaele Milan, Italy
  • Kawasaki University Kawasaki, Japan
  • Mie University Mie, Japan
View all 13 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Arizona Oncology Associates PC NAHOA Prescott, Arizona, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
View all 250 locations
View Trial Details
Recruiting

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

NCT04184973

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • University of California Irvine Irvine, California, United States
  • Kaiser Permanente San Diego medical Center San Diego, California, United States
  • Colorado University Anschutz Medical Campus Aurora, Colorado, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Recruiting

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Start Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • Dana-Farber/Massachusetts General Hospital, Inc Boston, Massachusetts, United States
  • New Experimental Therapeutics of San Antonio LLC San Antonio, Texas, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

NCT06662786

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • CBCC Global Research Bakersfield, California, United States
View all 237 locations
View Trial Details

Related conditions